Replies to post #89090 on Biotech Values

[poorgradstudent]

>How long should the analysis take, IYO?<

If survival is the endpoint and they just confirmed the triggering event, they have all the necessary data in hand*. And I'm sure they have computers.

1 week. Max.


All the delay does is hurt/deprive patients, and leave investors open to disclosure shenanigans.

All imo, of course. However, I've become more and more outraged with trial disclosure policies of biotechs and the medical community.


* I understand the need to verify the timing of each event, but that can be done reliably and efficiently in real-time as the events occur.